Zhejiang Jianfeng Group (600668) Fair Value & Analysis
Basic Materials · CN · Market cap 3.1B CNY
Fair value as of: Aug 9, 2026
From 14 valuation models · updated yesterday
Fair value updated Aug 9, 2026, revised from ¥12.44 to ¥10.65 (−14.4%) since Jul 11, 2026. Share price +5.7% over the past month.
Below-average quality, screening 41% undervalued on our models.
What matters now
- The large discount to fair value meets weak quality (44/100). That raises the risk this is a value trap rather than a bargain.
- The price is below even our cautious bear case (¥7.99). The market is more pessimistic than our downside scenario.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 9, 2026.
How to read this chart
60‑month range ¥6.33 – ¥18.36 · fair‑value band ¥7.99 – ¥13.32 · the ¥7.58 price screens below the ¥10.65 fair value. Dashed = 300-day average. As of Aug 9, 2026.
Analysis
Zhejiang Jianfeng Group (600668) currently trades at ¥7.58, while our model-based Fair Value estimate is ¥10.65, implying the stock looks roughly 40.6% undervalued today. The Quality Score stands at 44/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Zhejiang Jianfeng Group generated revenue of 2.5B CNY at a net margin of -7.5%. Revenue declined 8.1% year over year. It earns a return on equity of -3.6%. Net debt stands at 501M CNY. Fundamentals as of Aug 9, 2026
Our scenario range runs from ¥7.99 (bear case) to ¥13.32 (bull case); at ¥7.58, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 44% below its 52-week high and 4% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -59% fair-value upside, at 41%, 600668 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 14 models by family
Widest divergence: Growth Earnings (¥17.51) versus Economic Profit (¥0.8800). Highest evidence: Residual Income (76).
Notify me when 600668 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 9, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 45 · Market factors (momentum, volatility) 31
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Zhejiang Jianfeng Group Co., Ltd. engages in the building materials and pharmaceuticals business in China. The company offers pharmaceutical products, including antibiotics, cardiovascular drugs, antidepressants, ophthalmic drugs, anti-tumor drugs, and infant medications.
Full company description
Zhejiang Jianfeng Group Co., Ltd. engages in the building materials and pharmaceuticals business in China. The company offers pharmaceutical products, including antibiotics, cardiovascular drugs, antidepressants, ophthalmic drugs, anti-tumor drugs, and infant medications. It is involved in investment in pharmaceutical and healthcare industries; manufacturing and sales of cement and cement concrete; production and sales of pharmaceutical intermediates; sales of pharmaceutical chemical raw materials; and import and export business; and other industrial investments. Zhejiang Jianfeng Group Co., Ltd. was incorporated in 1989 and is based in Jinhua, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Zhejiang Jianfeng Group reported revenue of ¥2.6B in FY2025 versus ¥3.8B in FY2021, a compound −9.4%/yr. Reported net income was ¥412M in FY2025, compounding −18.3%/yr from FY2021.
of which total revenue +3.8 pp · buybacks/dilution −0.7 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch 600668: get an alert when its fair value changes →
Peer Group
Building Materials · 253 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Building Materials median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Building Materials stocks, each showing price versus our Fair Value estimate (as of Aug 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| CRH plc CRH | $102.92 | $70.57 | -31% |
| UltraTech Cement Limited ULTRACEMCO | ₹11,711 | ₹4,719 | -60% |
| China Jushi Co 600176 | ¥54.52 | ¥13.95 | -74% |
| Grasim Industries Limited GRASIM | ₹3,073 | ₹1,245 | -59% |
| CEMEX, S.A. CEMEXCPO | 21.71 MXN | 15.42 MXN | -29% |
| Anhui Conch Cement Company 600585 | ¥16.99 | ¥26.14 | +54% |
| Ambuja Cements Limited AMBUJACEM | ₹435.25 | ₹227.96 | -48% |
| Shree Cement Limited SHREECEM | ₹26,930 | ₹8,215 | -69% |
| TCC Group 1101B | 43.70 TWD | 10.48 TWD | -76% |
| Taiwan Glass Ind. Corp 1802 | 53.30 TWD | 13.98 TWD | -74% |
Compare Zhejiang Jianfeng Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Zhejiang Jianfeng Group (600668) overvalued or undervalued?
What is the fair value of 600668?
What is the quality score of 600668?
What is the revenue of Zhejiang Jianfeng Group (600668)?
What is the net profit margin of 600668?
Does Zhejiang Jianfeng Group pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Zhejiang Jianfeng Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.